For instance, studies have shown that the constitutively active retinoblastoma tumor suppressor can attenuate the expression of specific dNTP synthetic cellular enzymes, including DHFR, RRM1, RRM2, and thymidylate synthase (TS) [145]. This evidence concerns the gene RRM2 and retinoblastoma.